Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a

Florim Cuculi1, Adrian P Banning, Alexander Abizaid

  • 1Oxford Heart Centre, Oxford, UK.

Insights

Multivessel percutaneous coronary intervention (PCI) showed excellent outcomes but had higher rates of periprocedural myocardial infarction and major adverse cardiac events (MACE) compared to single-vessel PCI in a large real-world study.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Device Research

Background:

  • Percutaneous coronary intervention (PCI) for multiple coronary lesions offers economic and social benefits.
  • Limited real-world data exists on the comprehensive outcomes of multivessel PCI.
  • The e-SELECT registry provides a large dataset to evaluate these outcomes.

Purpose of the Study:

  • To compare short- and long-term outcomes of single-vessel versus multivessel PCI.
  • To analyze data from the e-SELECT registry, which includes patients treated with sirolimus-eluting stents (SES).
  • To assess rates of myocardial infarction and major adverse cardiac events (MACE).

Main Methods:

  • Retrospective analysis of the e-SELECT registry data.
  • Inclusion of 15,147 patients undergoing either single-vessel or multivessel PCI.
  • Comparison of outcomes including myocardial infarction and MACE between the two groups.

Main Results:

  • Multivessel PCI patients were slightly older with higher diabetes prevalence.
  • Higher rates of periprocedural myocardial infarction (1.9% vs 0.8%) in the multivessel PCI group.
  • One-year MACE rates were significantly higher in the multivessel PCI group (6.1% vs 4.6%).

Conclusions:

  • Both single- and multivessel PCI demonstrated excellent procedural and one-year outcomes.
  • Multivessel PCI was associated with increased periprocedural myocardial infarction and MACE.
  • Despite lower lesion complexity, multivessel PCI carries a higher risk in real-world practice.
Abstract